Vaccine against Ebola: Commission grants new market authorisations

Ebola vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola. The authorisation was granted in one month, reducing the decision-making process timing in half, further demonstrating the Commission’s commitment in placing the protection of public health as a priority.

The new Ebola vaccine, which consists of two components, called Zabdeno and Mvabea, had been in development with the support of the Commission. This decision follows a recommendation from the European Medicines Agency (EMA), which has assessed the benefits and risks of the vaccine.

Stella Kyriakides, Commissioner in charge of Health and Food Safety, said: “This is the second Ebola vaccine that the Commission authorises in less than a year and confirms once again that the EU remains at the forefront of the global effort to save lives from this virus. We know very well from the coronavirus crisis that viruses do not respect borders – protecting the health of others protects the health of all.”

Mariya Gabriel, Commissioner in charge of Research, said: Today, we can be glad to have supported the development of the Ebola vaccine with EU funding, in partnership with the European pharmaceutical sector under the Innovative Medicines Initiative. The investment from the EU’s research programme Horizon 2020 into several Innovative Medicines Initiative Ebola projects is now bearing fruit. This demonstrates, yet again, the power of collaboration and European R&I leadership to tackle global health threats. “

As explained by EMA when it recommended the approval last February, the ability of the immune system to respond to the virus after vaccination with Zabdeno and Mvabea was studied in a total of 3,367 adults, adolescents and children who participated in five clinical studies conducted in Europe, Africa and the US.

The development of the vaccine is the result of rigorous work by several projects funded with just over €130 million through the Innovative Medicines Initiative (IMI), which is partly supported by the EU’s research and innovation programme, Horizon 2020. Following a comprehensive approach, the EBOVAC 1, 2 & 3, projects assessed the safety and tolerability of the Ebola vaccine regimen through clinical trials in Europe and Africa. The EBODAC project developed a communication strategy and tools to promote the acceptance and uptake of new Ebola vaccines. Finally, the EBOMAN project focused on accelerating the development and manufacture of the vaccine.

Background

The authorisation of a medicine under the centralised procedure is a two-stage process, involving the European Medicines Agency (EMA) and the Commission. EMA assesses the benefits and risks of medicines and makes recommendations to the Commission, which then takes a final legally binding decision on whether or not the medicine can be marketed in the EU.

This decision is issued normally within the legal deadline of 67 days of the scientific opinion of EMA (for Zabdeno and Mvabea the date was 28 May). This phase includes, among other things, the translation of the product guidelines in all EU languages and a consultation with Member States. In view of the public health interest, the Commission has accelerated this process and authorised the medicine in around a month, in other words reducing the time taken for the decision-making process in half.

The assessment report for the vaccines will be published on EMA’s website.

IMI funds large-scale collaborative research projects bringing together academic and industrial partners, as well as patients and other stakeholders.

In November 2014, IMI responded very rapidly to the West Africa outbreak of Ebola by allocating €280 million to a comprehensive call for proposals to tackle a wide range of challenges in Ebola research, including vaccines development, clinical trials, storage and transport, as well as diagnostics. The first projects under the IMI Ebola+ programme started as early as January 2015 and several focused on the development of the Janssen vaccine regimen. Since 2014, IMI has funded 12 projects on Ebola and related diseases with a total combined budget of over EUR 300 million.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Italy’s dilemma after Merkel-Hollande agreed loose banking union

High anxiety calls for innovation in digital mental health

Statement by the European Commission following the first meeting of the EU-UK Joint Committee

George Floyd: these are the injustices that led to the protests in the United States

GSMA Mobile 360 in Kuala Lumpur– Digital Societies, in association with The European Sting

Brexit talks: 2nd round fails to bring the EU and the UK closer on key issues

Environmental labelling, information and management schemes are central to the circular economy

How the EU sees its own and Russia’s role in Ukraine

How the tech sector can power the shift to a sustainable economy

Pakistan: UN Security Council condemns ‘heinous and cowardly’ terrorist attacks

Dare to be vulnerable, and three other lessons in leadership

Mergers: Commission refers acquisition of newly created joint venture by Telefónica and Liberty Global to the UK competition authority

Improve collection of data on disasters, Secretary-General Guterres urges

Inclusion, equality a must for ‘long-lasting peace and sustainable development’, UN official tells high-level event in Baku

How cities can become more resilient to climate change

North-east Nigeria displacement crisis continues amid ‘increased sophistication’ of attackers, warns UN

Learn from the margin, not the center: digital innovation with social impact as transformative force bridging digital divide

2014 will bring more European Union for the big guys and less for the weak

Companies can help solve water scarcity. Here’s how

South Africa still hasn’t won LGBTQ+ equality. Here are 5 reasons why

3.7 million lives could be saved by 2025 if health services ramp up nutrition actions: WHO

The Commission unsuccessfully pretends to want curbing of tax evasion

Sudan: UN chief deplores excessive force used against pro-democracy protesters, calls on military and civilian leaders to ‘stay the course’ in negotiations

UN ‘stands in solidarity’ with cyclone-hit India – Secretary-General Guterres

The new assembly lines: Why AI needs low-skilled workers too

FROM THE FIELD: Chad returnees’ reluctant homecoming

Immigration crisis at its very worst: EU to outsource rescue business to North Africa?

This man is installing 100 trash barriers in Bali’s rivers to stop plastic pollution

Call to revitalize ‘language of the ancestors’ for survival of future generations: Indigenous chief

Yemen hospital airstrike under investigation amid resurgence of deadly cholera

5G will drive Industry 4.0 in the Middle East and Africa

The UK is on a record-breaking run of coal-free power

4 steps for looking after our mental health during these unsettling times

Remarks by H.E. Ambassador Zhang Ming At the Reception in Celebration of the 70th Anniversary of the Founding of the People’s Republic of China

Paid paternity leave should be the norm in the US

Young people are not a nameless, faceless mass. So why do we treat them as such?

Deaths from far-right terrorism have more than tripled in the West

What happiness can teach us about how we measure human development

A for-profit project has improved nutrition in Rwanda – is it a model that can eliminate hunger across Africa?

Guinea-Bissau needs ‘genuinely free and fair elections’ to break cycle of instability

VAT: EU Member States still losing almost €150 billion in revenues according to new figures

Malta: MEPs conclude fact-finding visit to assess Caruana Galizia murder inquiry

FROM THE FIELD: Malawi farmers diversify to fight climate change

How technology is driving a fourth wave of environmentalism

Ben Stiller’s new role, more about hope than humour, as he’s named Goodwill Ambassador for UNHCR

European Commission: the LED lights of your Audi A6 shall save our planet

Sweden has a plan to end all traffic accident deaths

Autumn 2019 Economic Forecast: A challenging road ahead

Technology as an inclusion method while facing the COVID-19 pandemic: the “Coronavirus-SUS” app

Coronavirus: here’s what you need to know about face masks

MEPs back plans to promote water reuse for agricultural irrigation

Poor quality is healthcare’s silent killer. Here’s what we can do about it

COVID-19 vaccines: EU must respond with unity and solidarity

COP21 Breaking News: “There is an ecological debt that the world needs to pay back to Africa”, French President Francois Hollande promises 2 Billion euros by 2020 from Paris

IMAGINATION, FACTS AND OPPORTUNITIES – THE UNLIMITED POWER OF CHINA

Russia and the West use the same tactics to dismember Ukraine

The IMF overstates the risks for Eurozone and downgrades the threats for the US economy

EU helps tackle air pollution in Kosovo with €76.4 million

In polarized America, a new divide looms

How COVID-19 will change the way we design our homes

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s